[1] Lin X, Hou W, Lu J, et al. Clinical study of entecavir combined with microecological preparations on liver function and prognosis in patients with hepatitis B cirrhosis. J Perinat Med, 2016,32: 993-995.
[2] 夏海珊,陈少茹,钟月春等.肝纤维化的发病机制和药物治疗现况.中国医药导报,2014,26:162-165,168.
[3] 刘芳,魏琳,王珊珊,等.瞬时弹性成像技术联合血清学指标对慢性乙型肝炎肝纤维化的诊断价值研究.中国全科医学,2016,19:3039-3044.
[4] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年版).中国肝脏病杂志(电子版),2015,6:1-18.
[5] 李楚天,何青莲,罗碧怡等.慢性肝炎患者肝脏炎症程度与肝纤维化的关系.广东医学,2014,21:2713-2714.
[6] Zhang H, Zhou T, Qian X, et al. Clinical anatomy of the right branch of the hepatic portal vein. J Anat, 2015, 19: 264-268.
[7] 葛娜.超声弹性成像对肝纤维化分级的评估.临床肝胆病杂志,2016,32:2379-2382.
[8] Jo K,Mitchell DG,Gabata T. Enlargement of hilarperiportal space: a sign of early cirrhosis at MR imaging.J Magn Reson Imaging,2000,11:136-140.
[9] 王荣琦,任伟光,赵素贤,等.瞬时弹性成像技术与多参数模型评估慢性肝病肝纤维化程度的临床研究.中华肝脏病杂志,2015,23:265-269. |
